| 03-Nov-2010 | S | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 03, 2010, inter alia, has approved the following:
The Board has approved the sub-division of equity shares of the face value of Rs. 5/- each in the Company into equity shares of the face value of Re. 1/- each. The sub-division would be subject to the approval of the shareholders and such other approvals as may be necessary.
Aurobindo Pharma Ltd has informed BSE that the shareholders at the Extraordinary General Meeting (EGM) of the Company held on December 23, 2010, have approved the sub-division of one equity share of the face value of Rs. 5/-each in the Company into five equity shares of the face value of Rs. 1/- each.
(As Per BSE Announcement Website Dated on 23/12/2010)
SUB. :- Sub Division of equity shares of Aurobindo Pharma Limited (Scrip Code 524804)
Trading Members of the Exchange are hereby informed that, Aurobindo Pharma Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Aurobindo Pharma Limited (524804 & 624804)
RECORD DATE
11.02.2011
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.5/- each into FIVE equity shares of Re.1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
10/02/2011 DR- 222/2010- 2011
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re. 1/- paid up w.e.f. 10/02/2011.
ii. ISIN No. INE 406 A01029 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 10/02/2011.
iii. The new ISIN Number for Re.1- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 04.01.2011) | 11-Feb-2011 | |
| 07-Oct-2003 | S | Sub Division of existing equity shares from every ONE existing equity share of Rs.10/- each into TWO equity shares of Re.5/- each.
REDUCED PAID-UP VALUE - Rs.5/-
REDUCED PAID-UP VALUE W.E.F. - 23/10/2003 | 31-Oct-2003 | |
| 10-Feb-2024 | D | Board of Directors in their meeting held today, February 10, 2024, approved the payment of Second Dividend of 150% i.e. Rs.1.50 per shares of Re.1 each. | 20-Feb-2024 | |
| 09-Nov-2023 | D | The Board of Directors of the Company at its meeting held today, November 9, 2023, has inter alia, transacted the following items of business:
Approved first interim dividend of 300% i.e., Rs.3.00 (Rupees three only) per equity share of Re.1/- each on the equity share capital of the Company. The Company has already fixed November 20, 2023 as the record date for the purpose of payment of interim dividend for the financial year 2023-24 and the said interim dividend will be paid on or before December 4, 2023. | 20-Nov-2023 | |
| 09-Feb-2023 | D | The Board of Directors of the Company at its meeting held today, February 9, 2023, has inter alia, transacted the following items of business:
Approved first interim dividend of 300% i.e. Rs.3.00 (Rupees three only) per equity share of Re.1/- each on the equity share capital of the Company. The Company has already fixed February 17, 2023 as the record date for the purpose of payment of interim dividend for the financial year 2022-23. The interim dividend will be paid on or before March 3, 2023. | 17-Feb-2023 | |
| 30-May-2022 | D | The Board of Directors of the Company at its meeting held today, May 30, 2022, has inter alia, approved fourth interim dividend of 450% i.e. Rs.4.50 (Rupees four and paise fifty) per equity share of Re.1/- each on the equity share capital of the Company. The Company has already fixed June 7, 2022 as the record date for the purpose of payment of fourth interim dividend for the financial year 2021-22. The interim dividend will be paid on or before June 15, 2022. | 06-Jun-2022 | |
| 09-Feb-2022 | D | The Board of Directors of the Company at its meeting held today, February 9, 2022, has, inter alia, considered and approved:-
Third Interim Dividend @ 150% i.e. Rs.1.50 (Rupee one and paise fifty) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2021-22. The Company has fixed February 21, 2022 as the Record Date for the purpose of payment of Third Interim Dividend and the same will be paid on or before March 4, 2022.
| 18-Feb-2022 | |
| 08-Nov-2021 | D | The Board of Directors of the Company at its meeting held today, November 8, 2021, has, inter alia, considered and approved:-
Second Interim Dividend @ 150% i.e Rs.1.50 (Rupee one and paise fifty) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2021-22. The Company has fixed November 18, 2021 as the Record Date for the purpose of payment of Second Interim Dividend and the same will be paid on or before November 30, 2021.
We also enclose a copy of the Press Release on Un-audited Financial Results of the Company for the Second Quarter and half year ended September 30, 2021.
| 17-Nov-2021 | |
| 12-Aug-2021 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2021, inter alia, has considered and approved an Interim Dividend @ 150% i.e. Rs. 1.50 (Rupee one and paise fifty) per equity share of Re. 1/- each on the equity share capital of the Company for the Financial Year 2021-22 and the same will be paid on or before September 07, 2021. | 27-Aug-2021 | |
| 10-Feb-2021 | D | The Board of Directors of the Company at its meeting held today, February 10, 2021, has, inter alia, considered and approved:
Third Interim Dividend @ 150% i.e Rs.1.50 (Rupee one and paise fifty) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2020-21. The Company has fixed February 23, 2021 as the Record Date for the purpose of payment of Third Interim Dividend and the same will be paid on or before March 4, 2021.
The Board meeting commenced at 4.00 p.m. and concluded at 6.40 p.m. | 22-Feb-2021 | |
| 11-Nov-2020 | D | The Board of Directors of the Company at its meeting held today, November 11, 2020, has, inter alia, considered and approved:-
a Second Interim Dividend @ 125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2020-21. The Company has fixed November 24, 2020 as the Record Date for the purpose of payment of Second Interim Dividend and the same will be paid on or before December 4, 2020. | 23-Nov-2020 | |
| 12-Aug-2020 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2020, inter alia, has approved an Interim Dividend @ 125% i.e. Rs. 1.25 (Rupee one and paise twenty five) per equity share of Re. 1/- each on the equity share capital of the Company for the Financial Year 2020-21. | 21-Aug-2020 | |
| 06-Feb-2020 | D | The Board of Directors of the Company at its meeting held today, February 6, 2020, has inter alia, approved a Second Interim Dividend @ 175% i.e Rs.1.75 (Rupee one and paise seventy five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2019-20. The Company has fixed February 18, 2020 as the Record Date for the purpose of payment of Second Interim Dividend and the same will be paid on or before March 2, 2020. | 17-Feb-2020 | |
| 12-Nov-2019 | D | The Board of Directors of the Company at its meeting held today,November 12,2019,has interalia, transacted the following businesses:
Approved an Interim Dividend @ 125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2019-20. The Company has fixed November 23,2019 as the Record Date for the purpose of payment of Interim Dividend and the same will be paid on or before December 4, 2019.
We enclose a copy of the Press Release on Unaudited Financial Results of the Company for the second quarter and half year ended September 30,2019. | 21-Nov-2019 | |
| 07-Feb-2019 | D | The Board of Directors of the Company at its meeting held today, February 7, 2019, has inter alia, approved a Second Interim Dividend @125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2018-19. The Company has fixed February 19, 2019 as the Record Date for the purpose of payment of Second Interim Dividend and the same will be paid on or before February 28, 2019. | 15-Feb-2019 | |
| 12-Nov-2018 | D | The Board of Directors of the Company at its meeting held on 12th November, 2018 has inter alia, approved Interim Dividend @125% i.e Rs.1.25/- (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2018-19. The Company has fixed 22nd November, 2018 as the Record Date for the purpose of payment of Interim Dividend and the same will be paid on or before 30th November, 2018. | 20-Nov-2018 | |
| 07-Feb-2018 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 07, 2018, inter alia, has approved second interim dividend @100% i.e. Re.1 (Rupee One only) per equity share of Re.1 (Rupee One only) for the year 2017-18. | 20-Feb-2018 | |
| 09-Nov-2017 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 09, 2017, inter alia, has considered & approved interim dividend @150% i.e. Rs. 1.50 (Rupee One & paise fifty only) per equity shares of Re 1/- each on the equity share capital of the Company for the year 2017-18.
The Interim Dividend will be paid on or before November 30, 2017. | 21-Nov-2017 | |
| 30-May-2017 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2017, inter alia, has considered and approved second interim dividend of 125% i.e. Rs.1.25 (Rupee one and paise twenty five only) per equity share of Re.1/- each on the equity share capital of the Company for the financial year 2016-17.
The Company has paid first interim dividend of 125% i.e. Rs.1.25 (Rupee one and paise twenty five only) per equity share of Re.1 each in the month of December 2016 on the equity share capital of the Company for the financial year 2016-17.
Thus the total dividend, including the second interim dividend for the financial year 2016-17 will aggregate to 250% i.e. Rs.2.50 (Rupee two and paise fifty only) per equity share of Re.1/- each on the equity share capital of the Company.
The Board of Directors has not recommended any final dividend for the financial year 2016-17.
The Board of Directors of the Company at its meeting held on 29th May 2017 has inter-alia considered and approved second interim dividend of 125% i.e Rs.1.25 (Rupee one and paise twenty five only) per equity share of Re.1/- each on the equity share capital of the Company for the financial year 2016-17.
The Company has fixed 9th June 2017 as the Record Date for the purpose of payment of Second Interim Dividend for the financial year 2016-17. The Interim Dividend will be paid on or before 21st June 2017.
The Board of Directors has not recommended any final dividend for the financial year 2016-17. | 08-Jun-2017 | |
| 14-Nov-2016 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 14, 2016, inter alia, has approved an interim dividend @125% i.e. Re. 1.25 (One Rupee and Paise twenty five only) per equity share of Re. 1/- (Rupees One only) for the year 2016-17.
The Board of Directors of the Company at its meeting held on 29th May 2017 has inter-alia considered and approved second interim dividend of 125% i.e Rs.1.25 (Rupee one and paise twenty five only) per equity share of Re.1/- each on the equity share capital of the Company for the financial year 2016-17.
The Company has fixed 9th June 2017 as the Record Date for the purpose of payment of Second Interim Dividend for the financial year 2016-17. The Interim Dividend will be paid on or before 21st June 2017.
The Board of Directors has not recommended any final dividend for the financial year 2016-17.
(As per BSE Announcement date on 29/05/2017) | 24-Nov-2016 | |
| 30-May-2016 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has considered and approved fourth interim dividend of 70% (Re. 0.70 per equity share of Re. 1/- each) on the equity share capital of the Company for the year 2015-16.
The Company has paid first interim dividend of 50% (Re.0.50 per equity share of Re.1 each) in the month of September 2015, second interim dividend of 60% (Re. 0.60 per equity share of Re. 1 each) in the month of November, 2015 and third interim dividend of 70% (Re. 0.70 per equity share of Re. 1 each) in the month of March, 2016 on the equity share capital of the Company for the year 2015-16.
Thus the total dividend, including the fourth interim dividend for the year ended March 31, 2016 will aggregate to 250% (Rs. 2.50 per equity share of Re. 1/- each) on the equity share capital of the Company for the year 2015-16.
The Board of Directors does not recommend any further dividend for the year 2015-16. | 09-Jun-2016 | |
| 09-Feb-2016 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 09, 2016, inter alia, has considered and approved third interim dividend of 70% i.e. Re. 0.70 (Paise seventy only) per equity share of Re. 1/- each for the year 2015-16.
The Company had paid first interim dividend of 50% i.e., Re. 0.50 (Paise fifty only) per equity share of Re. 1/- each and second interim dividend of 60% i.e., Re. 0.60 (Paise sixty only) per equity share of Re. 1/- each for the year 2015-16 in September 2015 and November 2015 respectively.
The Third Interim Dividend will be paid on or before March 01, 2016. | 18-Feb-2016 | |
| 06-Nov-2015 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 06, 2015, inter alia, has considered and approved second interim dividend of 60% i.e. Re. 0.60 (Paise sixty only) per equity share of Re. 1/- each on the equity share capital of the Company for the year 2015-16.
The Company in the month of September 2015 had paid first interim dividend of 50% i.e. Re. 0.50 (Paise fifty only) per equity share of Re. 1/- each on the equity share capital of the Company for the year 2015-16. | 19-Nov-2015 | |
| 12-Aug-2015 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2015, inter alia, has considered and approved interim dividend of 50% i.e. Re. 0.50 (Paise fifty only) per equity share of Re. 1/- each on the equity share capital of the Company for the year 2015-16.
The Interim Dividend will be paid on or before 4th September, 2015.
With reference to the earlier annoucement dated May 28, 2015, regarding the Register of Members and Share Transfer Books of the Company is being closed from August 25, 2015 to August 27, 2015 (both days inclusive) for the purpose of 28th Annual General Meeting of the Company.
Aurobindo Pharma Ltd has now informed BSE that the aforesaid book closure dates will also be considered to determine the entitlement of the shareholders to the interim dividend of 50% i.e Re. 0.50 (Raise fifty only) per equity share of Re.1/- each on the equity share capital of the Company for the year 2015-16 as approved by the Board on August 12, 2015.
(As Per BSE Announcement Dated on 12/08/2015) | 21-Aug-2015 | |
| 28-May-2015 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2015, inter alia, has considered and approved third interim dividend of 100% (Re.1 per equity share of Re. 1/- each) on the equity share capital of the Company for the year 2014-15.
The Board of directors do not recommend any further dividend for the year 2014-15. | 08-Jun-2015 | |
| 05-Feb-2015 | D | Aurobindo Pharma Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 04, 2015 has inter-alia considered and approved
second interim dividend of 200% i.e Rs.2.00 (Rupees two only) per equity share of Re.1/- each on the equity share capital of the Company for the year 2014-15.
The Company in the month of September 2014 had paid first interim dividend of 150% i.e Rs.1.50 (Rupee one and paise fifty only) per equity share of Re.1/- each on the equity share capital of the Company for the year 2014-15.
| 16-Feb-2015 | |
| 07-Aug-2014 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 07, 2014, inter alia, has considered & approved Interim dividend of 150% i.e. Rs.1.50/- (Rupee one and paise fifty only) per share of Re. 1/- each on the equity share capital of the Company for the year 2014-15.
The Interim Dividend will be paid on or before September 05, 2014. | 13-Aug-2014 | |
| 30-May-2014 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has approved a second interim dividend @175% on the equity share capital of the Company i.e. Rs.1.75/- per share. This is in addition to interim dividend @125% on equity share capital of the Company i.e. Rs. 1.25 per share paid in November, 2013. The Board of directors do not recommend any further dividend for the year 2013-14, | 11-Jun-2014 | |
| 08-Nov-2013 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 07, 2013, inter alia, has approved payment of an Interim Dividend @ 125% i.e., Rs.1.25 (Rupee one and paise twenty five only) per Equity Share of Re. 1/- (Rupee one only) each to the members of the Company for the Financial Year 2013-14.
The Interim Dividend will be paid on or after November 27, 2013 | 19-Nov-2013 | |
| 30-May-2013 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has considered and approved the following :
- The final dividend at 50% (Re.0.50 per equity share of Re. 1/- each) on the equity share capital of the Company for the year 2012-13 has been recommended, subject to approval of members. The Company in the month of February 2013 has paid an interim dividend of 100% (Re. 1.00 per equity share of Re. 1/- each) on the equity share capital of the Company for the year 2012-13. | 30-Jul-2013 | |
| 07-Feb-2013 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 07, 2013, inter alia, has approved an interim dividend @100% i.e. Re.1/- (Rupees One Only) per equity share of Re. 1 (Rupees One only) for the year 2012-13. | 18-Feb-2013 | |
| 30-May-2012 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2012, inter alia, has recommended final dividend @ 100% on the equity share capital of the Company i.e. Re. 1/- per share subject to approval of members. | 30-Jul-2012 | |
| 09-May-2011 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 09, 2011, inter alia, has recommended final dividend at 100% (Re. 1.00 per share of Re. 1/- each) on the equity share capital of the Company for the year 2010-2011, subject to approval of members. The Company in the month of November, 2010 has paid an interim dividend of 100% (Rs. 5.00 per share of Rs. 5/- each) on the equity share capital of the Company for the year 2010-2011. | 20-Jul-2011 | |
| 03-Nov-2010 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 03, 2010, inter alia, has approved the following:
The Board has approved an interim dividend of 100% i.e. Rs. 5/- per equity share of Rs. 5/- each. | 11-Nov-2010 | |
| 30-May-2010 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2010, inter alia, has recommended final dividend @ 40% on the equity share capital of the Company i.e. Rs. 2/- per share subject to approval of members. This is in addition to interim dividend @ 60% on equity share capital of the Company i.e. Rs 3/- per share paid in February 2010. | 13-Sep-2010 | |
| 30-Jan-2010 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 30, 2010, inter alia, has approved payment of an Interim Dividend @ 60% i.e. Rs. 3/- (Rupees three only) per Equity Share of Rs. 5/- (Rupees five only) each to the members of the Company for the Current Financial Year 2009-2010. | 05-Feb-2010 | |
| 12-Nov-2009 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 12, 2009, inter alia, has considered and approved the following :
The final dividend at 30% (Rs. 1.50 per share of Rs. 5/- each) on the equity share capital of the Company for the year 2008-09 has been recommended, subject to approval of members at the ensuing Annual General Meeting to be held on December 23, 2009. The Company in the month of February, 2009 has paid an interim dividend of 60% (Rs. 3.00 per share of Rs. 5/- each) on the equity share capital of the Company for the year 2008-09. | 16-Dec-2009 | |
| 30-Jan-2009 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 30, 2009, inter alia, has approved payment of an Interim Dividend @ 60% i.e., Rs 3/- (Rupees three only) per Equity Share of Rs 5/- (Rupees five only) each to the members of the Company for the Current Financial Year 2008-2009. | 05-Feb-2009 | |
| 18-Jun-2008 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 18, 2008, inter alia, has recommended dividend of 65% (Rs 3.25 per share of Rs 5/- each) on its equity share capital of the Company for the year 2007-08 subject to approval of members at the ensuing Annual General Meeting. | 11-Aug-2008 | |
| 30-Jun-2007 | D | Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2007, inter alia, has recommended a dividend of 50% (Rs 2.50 per share of Rs 5/- each) on its equity share capital of the Company for the year 2006-07 subject to approval of members in the General Meeting.
| 14-Sep-2007 | |
| 02-Jul-2005 | D | 10% Dividend | 20-Sep-2005 | |
| 10-Jul-2015 | B | SUB. :- Bonus issue of Aurobindo Pharma Ltd. (Scrip Code: 524804)
Trading Members of the Exchange are hereby informed that, Aurobindo Pharma Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Aurobindo Pharma Ltd.
(424804; 524804; 624804)
RECORD DATE
21/07/2015
PURPOSE
Issue of 1 (ONE) Bonus equity share for every 1 (ONE) existing equity share held.
Ex-Bonus basis from Date & Sett. No.
20/07/2015 DR-077/2015-2016
Trading Members of the Exchange are requested to take note of it. | 21-Jul-2015 | 1:1 |
| 17-Jan-2025 | BC | AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve Intimation of Board Meeting to be held on | 06-Feb-2025 | |
| 13-Dec-2024 | BC | Intimation of retirement of Mrs.Savita Mahajan on completion of her second term as Independent Director of the Company. | 15-Dec-2024 | |
| 13-Sep-2024 | BC | Life Insurance Corporation of India
(Sale Dated on: 25/11/2021 to 12/09/2024) | 25-Nov-2024 | |
| 01-Nov-2024 | BC | AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve Intimation of Board meeting to be held on | 09-Nov-2024 | |
| 25-Oct-2024 | BC | GLS Pharma Ltd | 25-Oct-2024 | |